Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.13 - $2.77 $6,390 - $8,310
3,000 New
3,000 $8,000
Q1 2024

May 15, 2024

BUY
$2.04 - $2.38 $1,836 - $2,142
900 Added 900.0%
1,000 $2,000
Q4 2023

Feb 14, 2024

SELL
$2.03 - $2.77 $4,871 - $6,648
-2,400 Reduced 96.0%
100 $0
Q3 2023

Nov 14, 2023

SELL
$2.37 - $3.52 $4,503 - $6,688
-1,900 Reduced 43.18%
2,500 $6,000
Q2 2023

Aug 14, 2023

BUY
$3.45 - $4.47 $7,590 - $9,834
2,200 Added 100.0%
4,400 $15,000
Q1 2023

May 15, 2023

SELL
$3.55 - $4.23 $4,260 - $5,076
-1,200 Reduced 35.29%
2,200 $9,000
Q4 2022

Feb 14, 2023

BUY
$2.17 - $3.57 $7,378 - $12,138
3,400 New
3,400 $12,000

Others Institutions Holding KRMD

About KORU Medical Systems, Inc.


  • Ticker KRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 45,033,100
  • Market Cap $139M
  • Description
  • KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneou...
More about KRMD
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.